Differential effects of C5 inhibition, C3 inhibition, and alternative pathway inhibition on bacterial killing in vitro

Authors

Rob ter Heine (ORCID: https://orcid.org/0000-0003-2185-8201)
Nicole C. A. J. van de Kar (ORCID: https://orcid.org/0000-0002-1990-1189)
Mendy ter Avest (ORCID: https://orcid.org/0000-0001-5757-4919)
Jeroen D. Langereis (ORCID: https://orcid.org/0000-0001-5317-3202)
Marien I. de Jonge (ORCID: https://orcid.org/0000-0003-2812-5895)
Saskia Langemeijer (ORCID: https://orcid.org/0000-0002-0366-0800)
Zenno de Boer

Institutions

Radboud University Nijmegen (NL)
Radboud University Medical Center (NL)
Radboud Institute for Molecular Life Sciences (NL)

Publication Details

Journal: Blood Advances
Published: 2025-01-16
DOI: https://doi.org/10.1182/bloodadvances.2024013587
Citations: 5
Primary Topic: Complement system in diseases
Type: article
Field-Weighted Citation Impact: 3.99

Funders

Amgen
Alexion Pharmaceuticals
Apellis Pharmaceuticals
Radboud Universiteit
Radboud Universitair Medisch Centrum
European Rare Kidney Disease Reference Network

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Differential effects of C5 inhibition, C3 inhibition, and alternative pathway inhibition on bacterial killing in vitro

Rob ter Heine, Nicole C. A. J. van de Kar, Mendy ter Avest, Jeroen D. Langereis et al.

Jan 16, 2025

5 citations

Blood Advances

Complement system in diseases

3.99

article

Differential effects of C5 inhibition, C3 inhibition, and alternative pathway inhibition on bacterial killing in vitro

Rob ter Heine, Nicole C. A. J. van de Kar, Mendy ter Avest, Jeroen D. Langereis, Marien I. de Jonge, Saskia Langemeijer, Zenno de Boer

January 16, 2025article en

5 citations

Abstract

No abstract available for this paper.

Blood AdvancesVol. 9(6)

Radboud University Nijmegen (NL), Radboud University Medical Center (NL), Radboud Institute for Molecular Life Sciences (NL)

Amgen, Alexion Pharmaceuticals, Apellis Pharmaceuticals, Radboud Universiteit, Radboud Universitair Medisch Centrum, European Rare Kidney Disease Reference Network

Zero hunger

Openalex Percentile: Top 7%

Complement system in diseases

3.99

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Differential effects of C5 inhibition, C3 inhibition, and alternative pathway inhibition on bacterial killing in vitro — Rob ter Heine, Nicole C. A. J. van de Kar, et al. · Blood Advances (2025) | TGRS Research Map | TGRS